Home Headlines India Favipiravir quickens recovery, show trials - health

Favipiravir quickens recovery, show trials – health


Glenmark’s favipiravir hastens recovery among mild to moderate coronavirus disease (Covid-19) cases, the pharma major said as it announced results of its phase III clinical trials on Wednesday.

“Results from the Phase 3 trial showed numerical improvements for the primary efficacy endpoint with 28.6% faster viral clearance in the overall population as measured by the median time until cessation of oral shedding of virus in the Favipiravir treatment arm compared to those in the control arm…,” the company said in a statement.

“…40% faster achievement of clinical cure defined as the physician’s assessment of normalization of clinical signs – temperature, oxygen saturation, respiratory rate and cough with a statistically significant reduction in median time to clinical cure in the Favipiravir treatment arm (3 days)…, compared to the control arm (5 days)….”, the statement said. Favipiravir is a broad-spectrum oral antiviral drug that inhibits the Sars-Cov-2 virus, which causes Covid-19, from replicating.

Click here for the complete coverage of the Covid-19 pandemic

The India trials were conducted on 150 patients across seven clinical sites in India. The open-label randomized, multicenter clinical trial, evaluated the efficacy and safety of favipiravir plus standard supportive care (favipiravir treatment arm), versus standard supportive care alone (control arm), in mild to moderate cases.

“We are encouraged with the results and these indicate that early treatment with favipiravir may improve clinical outcomes for mild to moderate patients and could prevent patients from progressing to acute respiratory distress syndrome and mortality,” said Monika Tandon, vice president, and head, clinical development, Glenmark.

One of the principal investigators of the study, Dr Zarir Udwadia, said, “…I have had a chance to independently view the initial results and they are encouraging: Patients randomised to favipiravir seemed to have a faster clinical cure, and faster viral clearance than those randomized to the routine care group…”

Stay tune

110FansLike
400FollowersFollow

Most Popular

US helps India, China protests; Decision within the US Congress

The USA has lauded India's aggression in opposition to China within the wake of the Line of Management (LoC) battle in Ladakh.

In 24 hours, 1,007 individuals died and 64,553 new circumstances had...

The variety of coronary coronary heart illness sufferers within the nation is growing quickly. Greater than 60,000 coronary coronary heart illness sufferers...

Terrorist assault in Jammu and Kashmir, two policemen martyred; Search operation...

A police convoy has been attacked in Jammu and Kashmir. The assault happened within the Naugaon sector of Srinagar. Two policemen have...

Prashant Bhushan convicted of contempt of Supreme Courtroom, sentenced on August...

Senior lawyer Prashant Bhushan has been convicted by the Supreme Courtroom of contempt of courtroom. A photograph of Chief Justice Sharad Bobade...

Nishan-e-Pakistan award for separatist chief Syed Ali Shah Geelani in Jammu...

Former Hurriyat and separatist chief Syed Ali Shah Geelani has been honored by Pakistan on its Independence Day. On Friday, August 14,...

6 members of Mirza’s household together with BJP MLA contracted coronary...

Incumbent BJP MLA from Sangli-Miraj assembly constituency and former social justice minister Suresh Khade has contracted coronary heart disease.

One jawan martyred, one injured in Naxal firing in Gadchiroli

Gadchiroli: One policeman was killed and one other injured when Naxals opened fireplace on two jawans who had been on their option...

Swami was livid over the Air India sale supply to the...

Stated "If the deal goes forward, I'll file a felony criticism towards bigwigs within the authorities."